DIRS.INFO The most relevant business & tech news

☆ Moderna CEO: Plans to file Covid and flu combo shot with FDA by the end of the year
▼ + stars: | 2024-09-12 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailModerna CEO: Plans to file Covid and flu combo shot with FDA by the end of the yearStephane Bancel, Moderna CEO, joins 'Squawk Box' to discuss Moderna's recent stock performance, what could explain the stock's underperformance, and much more.

Persons: Stephane Bancel Organizations: Email Moderna, FDA, Moderna

☆ More free Covid tests will be available in late September, Biden admin says
▼ + stars: | 2024-08-23 | by ( Marlene Lenthang | Marlene Lenthang Is A Breaking News Reporter For Nbc News Digital. | ) www.nbcnews.com time to read: +1 min

Free Covid-19 tests will be available once again come late September, the Biden administration announced Friday. Under the program, four free Covid tests will be available by mail. “So as all of you prepare for travel and gatherings with family and the 2024 holiday season, don’t forget to go to Covidtests.gov to order your free tests,” she said. It comes as Covid rates have risen across most of the country over the summer, fueled by highly contagious new variants. Just Thursday, the Food and Drug Administration approved new Covid vaccines from Pfizer and Moderna, updated to better match the circulating strains of the virus.

Persons: Biden, Dawn O’Connell, O'Connell, ” Organizations: Department of Health, Human Services, Administration, Strategic Preparedness, Covid, Centers for Disease Control, Food and Drug Administration, Pfizer, Moderna Locations: Covidtests.gov

☆ New Covid shots are coming available. Here’s what experts say about when to get yours
▼ + stars: | 2024-08-23 | by ( Brenda Goodman | ) edition.cnn.com time to read: +5 min

CNN —Newly updated vaccines against Covid-19 will be in pharmacies soon, just as the US is experiencing a surge of infections. Experts say it depends on your health, whether you’ve recently had Covid-19, which vaccine you plan to get and when it’s convenient for you. For that reason, he’s going to hold off on getting the updated shot. Ranney noted that the updated mRNA shots from Pfizer and Moderna will probably be available first, with Novavax’s vaccine coming in a few weeks. “The reality is that we’ve had waves of Covid every summer for the last few years, and so I think we have to kind of do a reset or rethink about how we’re doing Covid vaccine delivery,” Hotez said.

Persons: you’ve, “ It’s, ”, Carlos del Rio, “, You’ve, Del, Paul Offit, Megan Ranney, Ranney, Peter Chin, “ I’m, I’m, you’re, ” Chin, Hong, Dr, Sanjay Gupta, Peter Hotez, ” Hotez Organizations: CNN, Covid, Emory University, Vaccine Education, Children’s Hospital of Philadelphia, Food, Yale School of Public Health, Pfizer, Moderna, University of California, ”, CNN Health, Texas Children’s Hospital Locations: Del Rio, San Francisco, Texas

☆ The rise of OpenAI and Microsoft's $13 billion bet on the AI startup
▼ + stars: | 2024-08-10 | by ( Magdalena Petrova | ) www.cnbc.com time to read: +1 min

OpenAI, the company behind the ChatGPT chatbot, was founded in 2015 by a number of researchers, academics and entrepreneurs, including Sam Altman, Greg Brockman and Elon Musk. At the time, OpenAI said Musk left to avoid a conflict of interest with his other company, Tesla , which was becoming increasingly focused on AI. In the years since, OpenAI has grown into one of the prominent leaders in AI development. OpenAI now reportedly generates annual revenue of $3.4 billion, and has notable customers, including PwC, Moderna and Estée Lauder. Microsoft has invested about $13 billion into the AI startup.

Persons: Sam Altman, Greg Brockman, Elon Musk, Altman, Brockman, Musk, OpenAI, Estée Lauder Organizations: Tesla, Moderna, Microsoft, Big Tech Locations: OpenAI

☆ Here are Monday's biggest analyst calls: Nvidia, Netflix, Apple, Walmart, Disney, Boeing, Robinhood, Berkshire Hathaway and more
▼ + stars: | 2024-08-05 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Morgan Stanley reiterates Disney as overweight Morgan Stanley lowered its price target on the stock to $110 per share from $130 but said it is sticking with Disney shares. Morgan Stanley upgrades Prosperity Bancshares to overweight from equal weight Morgan Stanley said the regional bank has "best in class capital and growing liquidity." Morgan Stanley initiates MKS Instruments as overweight Morgan Stanley said the controlling and measuring device manufacturing company is well positioned. Morgan Stanley reiterates Apple as overweight Morgan Stanley said it is sticking with the stock following its quarterly 10-Q report. " Morgan Stanley reiterates Walmart as overweight Morgan Stanley said it is sticking with its overweight rating on the stock following Walmart+ membership hitting a record high according to its survey checks.

Persons: Mizuho, Morgan Stanley, Disney, Lockheed Martin, Berkshire Hathaway, HOOD, Apple, Jefferies, Mars, Bernstein Organizations: Bank of America, Nvidia, Disney, Gulfport Energy, RBC, Lockheed, UBS, Berkshire, Berkshire Hathaway, Citi, RBC downgrades Moderna, Moderna, Walmart, underperform Bank of America, Netflix, Reuters, Kellanova, Boeing Locations: China, Gulfport, Berkshire, Underperform

☆ These stocks have fallen too much, too fast and could be due for a rebound after broad market sell-off
▼ + stars: | 2024-08-02 | by ( Hakyung Kim | ) www.cnbc.com time to read: +3 min

This week's market sell-off has pushed several stocks into oversold territory — potentially setting these names for a rebound in the future. Troubled cybersecurity stock CrowdStrike is the most oversold stock on the list with an RSI of just 13.6. Some of this week's most overbought companies include defense giant Lockheed Martin , tobacco company Philip Morris International and FirstEnergy . Of the names on the list, Lockheed Martin has the highest 14-day RSI reading of 93.7. LMT YTD mountain Lockheed Martin in 2024

Persons: Goldman Sachs, LULU, Lockheed Martin, Philip Morris Organizations: Nasdaq, Dow Jones, CNBC, Moderna, U.S, Street, Lockheed, Philip Morris International, Bank of America Locations: LSEG, Thursday's

☆ Three-Stock Lunch: Boeing, Moderna and Micron
▼ + stars: | 2024-08-02 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailThree-Stock Lunch: Boeing, Moderna and MicronScott Nations, president of Nations Indexes, joins CNBC's 'Power Lunch' to discuss three stocks: Boeing, Moderna, and Micron.

Organizations: Boeing, Moderna, Micron Scott Nations, Nations, Micron

☆ Stocks making the biggest moves midday: Shake Shack, C.H. Robinson, Mobileye Global and more
▼ + stars: | 2024-08-01 | by ( Sean Conlon | ) www.cnbc.com time to read: +5 min

However, it topped second-quarter revenue estimates and posted a narrower-than-expected loss for the quarter. Teladoc — The telehealth stock moved more than 4% lower after the company posted weaker-than-expected second-quarter revenue. Air Products and Chemicals — The industrial gases company's stock surged more than 10% after beating Wall Street's earnings expectations. MGM Resorts — The stock declined nearly 14% despite the casino operator surpassing second-quarter earnings expectations. Crocs — The stock shares fell about 2% even though the company surpassed second-quarter earnings and revenue expectations.

Persons: Shack, C.H, Robinson, Teladoc, LSEG, Royce —, Royce, Wall, Meta, Carvana, Crocs, Akash Palkhiwala, —, Samantha Subin, Yun Li, Michelle Fox Organizations: LSEG, Moderna, Royce, Air Products, Chemicals, Meta, MGM Resorts, MGM, Arm, Holdings, Qualcomm Locations: LSEG ., U.S

☆ Moderna CEO Stephane Bancel on Q2 results, slashing its full-year sales guidance
▼ + stars: | 2024-08-01 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailModerna CEO Stephane Bancel on Q2 results, slashing its full-year sales guidanceModerna CEO Stephane Bancel joins 'Squawk Box' to discuss the company's quarterly earnings results, why the company is slashing its full-year sales guidance, state of the company's Covid vaccines, and more.

Persons: Stephane Bancel Organizations: Email Moderna

☆ Stocks making the biggest moves premarket: Hershey, Meta Platforms, Arm Holdings, Shake Shack and more
▼ + stars: | 2024-08-01 | by ( Brian Evans | ) www.cnbc.com time to read: +3 min

Hershey — Shares were down 7% in the premarket after the chocolate maker posted second-quarter results that missed analyst expectations. Amazon — Stock in the e-commerce giant were roughly 2% higher ahead of second-quarter results after the closing bell on Thursday. Shake Shack — Shares were up nearly 9% in the premarket after the burger restaurant chain posted its second-quarter results. Shake Shack also raised the lower end of its full-year revenue guidance. MGM Resorts — The casino operator declined 3% despite posting second-quarter results that beat expectations.

Persons: LSEG, Michele Buck, Shack, Meta, Teladoc, Ferrari, Robinson, — CNBC's Hakyung Kim, Yun Li, Michelle Fox, Fred Imbert Organizations: Hershey —, Moderna, Holdings, —, MGM Resorts, MGM Locations: U.S, Europe

☆ Stock market today: Indexes tank as data paints a negative picture for the economy
▼ + stars: | 2024-08-01 | by ( Kelly Cloonan | ) www.businessinsider.com time to read: +2 min

US stocks nosedived on Thursday after several discouraging economic data points. The ISM manufacturing index dropped from 48.5% in June to 46.8% in July, marking an eight-month low. Investors are pricing in a 100% chance of Fed rate cuts in September, according to the CME FedWatch tool. Meanwhile, new data shows ISM manufacturing slid further into contraction territory in July. Jensen Huang just got $12 billion richer in a single day as Nvidia's stock soared on Wednesday.

Persons: —, Jerome Powell, Jensen Huang Organizations: Service, Reuters

☆ Moderna stock tumbles 21% as earnings show people aren't getting as many COVID shots
▼ + stars: | 2024-08-01 | by ( Kelly Cloonan | ) www.businessinsider.com time to read: +2 min

Moderna lowered its annual sales forecast as sales of its COVID-19 vaccine dropped by 37%. The company's vaccine sales struggled especially in Europe, where Pfizer has a deal until 2026. AdvertisementPeople are getting fewer COVID-19 shots, and it's hitting former vaccine heavyweight Moderna, new earnings show. The company's second quarter revenue dropped to $241 million, compared to $344 million a year ago, as sales of its COVID-19 vaccine dropped 37% year-over-year. Moderna also lowered its sales forecast for the year to between $3 billion and $3.5 billion, down from its previous forecast of around $4 billion.

Persons: —, it's, Stephane Bancel Organizations: Moderna, Pfizer, Service Locations: Europe, Moderna, Covid

☆ Moderna stock falls more than 10% as it slashes guidance on low EU sales, tough U.S. vaccine market
▼ + stars: | 2024-08-01 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +5 min

It's Moderna's second-ever commercially available product after its Covid vaccine, which has seen demand plunge as the world emerges from the pandemic and relies less on protective shots and treatments. He added that "we've been having quite intense discussions with governments across Europe" to get Covid vaccine supply from Moderna. He is referring to the European Union's massive renegotiated Covid vaccine supply contract with Pfizer and its German partner BioNTech . Its shares are up nearly 20% this year on increasing confidence around its pipeline and messenger RNA platform, which is the technology used in its Covid vaccine and RSV shot. Moderna is also developing a stand-alone flu shot, a personalized cancer vaccine with Merck and shots for latent viruses, among other products.

Persons: It's Moderna's, Stephane Bancel, we've, Bancel, BioNTech, Moderna, I'm Organizations: Moderna Inc, Moderna, Pfizer, GSK, LSEG, Wall, Research, Merck Locations: Cambridge , Massachusetts, Europe, U.S, Moderna, Ukraine

☆ S&P 500 futures rise after Meta posts quarterly beat: Live updates
▼ + stars: | 2024-07-31 | by ( Samantha Subin | ) www.cnbc.com time to read: +2 min

Stock futures rose in overnight trading Wednesday as investors weighed the latest corporate earnings reports, including strong results from Meta Platforms. S&P 500 futures gained 0.4%, while Nasdaq-100 futures jumped 0.6%. Futures tied to the Dow Jones Industrial Average added 30 points, or 0.1%. In extended trading, Meta Platforms rallied 7% on stronger-than-expected second quarter results and upbeat guidance. Stocks are coming off a winning session that saw the S&P 500 rally 1.58% for its best day since February.

Persons: Jerome Powell, Powell, Chris Zaccarelli Organizations: New York Stock Exchange, Stock, Meta, Nasdaq, Dow Jones, Meta Platforms, Arm Holdings, Federal Reserve, Independent, Alliance, Nvidia, Devices, VanEck Semiconductor, Apple, Dow, Intel, Booking Holdings, Moderna

☆ 14 earnings, jobs and the Fed are what we're watching in the market this week
▼ + stars: | 2024-07-27 | by ( Zev Fima | ) www.cnbc.com time to read: +12 min

As for Club earnings, we got positive results from life sciences company Danaher and industrial firm Dover. Ford was a major disappointment and its nearly 20% stock drop for the week was the worst performer in the portfolio. In the week ahead, it's going to be another big week of earnings with the four mega-cap names and 10 other Club names set to report. Linde : We're looking for more of the same — steady earnings growth; 6% is the Street estimate. End market commentary will also help us better formulate our view of the economy — and in turn the stock market.

Persons: Russell, Jerome Powell's, Ford, Stanley Black, Decker, We're, we'll, Elliott, we've, We'll, Kraft Heinz, Vita Coco, COCO, Lam, SIRI, WEN, Jim Cramer's, Jim Cramer, Jim, Michael M Organizations: Nasdaq, Dow, Communication, Honeywell, YouTube, Procter & Gamble, Devices, Microsoft, Starbucks, GE Healthcare, DuPont, Meta, Apple, Coterra Energy, Linde, Silo AI, Elliott Management, GE HealthCare, Amazon, Apple Intelligence, U.S, Labor, Fed, Networks, Procter, Gamble, PayPal, Pfizer, BP, JetBlue Airways, Merck, Solar Inc, Caesars Entertainment, Electronic Arts, EA, Nation Entertainment, Boeing, Cruise, Mastercard, Teva Pharmaceutical, Hess Corp, Arm Holdings, Qualcomm, Lam Research, Western, eBay, EBAY, MGM Resorts, MGM, ConocoPhillips, Mobileye, Canada Goose Holdings, Hershey, Toyota, Dominion Energy, Air Products & Chemicals, Southern Company, International, Coterra Energy Intel, Coinbase, Booking Holdings, LIN, Exxon Mobil, Chevron, LyondellBasell Industries, Jim Cramer's Charitable, CNBC, Traders, New York Stock Exchange, Santiago, Getty Locations: Dover, Eaton, Amazon, China, destocking, Corning, New York City

☆ Apple and Microsoft are among the 'Magnificent Seven' stocks set to report next week. Here's what that means
▼ + stars: | 2024-07-26 | by ( Sarah Min | ) www.cnbc.com time to read: +7 min

On Friday, the tech-heavy S & P 500 and Nasdaq Composite ended the week with losses, down 0.8% and 2.1%, respectively. However, the bulk of Magnificent Seven results is set for release in the week ahead. As it is, all seven of the Magnificent Seven companies closed out the week with losses. FOMC meeting, July jobs report Elsewhere, investors will also be reviewing the latest Federal Reserve interest rate decision set for release on Wednesday. Traders will also get insight into the labor market next week, with the release of the July jobs report on Friday.

Persons: Russell, Ryan Grabinski, John Belton, Tesla, Belton, FactSet, Stanley Black, Decker, Lam, Kraft Heinz, Ingersoll Rand Organizations: Nasdaq, Dow Jones Industrial, Microsoft, Facebook, Apple, Nvidia, 2H, 3Q, Gabelli, Traders, Dallas Fed, Semiconductor, Nation Entertainment, Electronic Arts, Starbucks, Match Group, Caesars Entertainment, Corning, Howmet Aerospace, Procter, Gamble, Pfizer, Merck, Co, PayPal, ADP, Civilian Workers, Chicago PMI, MGM Resorts International, Allstate, Lam Research, eBay, Qualcomm, Western, Cruise Line Holdings, Hess, Boeing, Mobile, Marriott International, GE Healthcare Technologies, Generac Holdings, Mastercard, Labor, PMI, Manufacturing, Intel, Holdings, Motorola Solutions, Technology, Air Products, Chemicals, Jobs, Exxon Mobil, Chevron Locations: Chicago, Albemarle, Kellanova, Hershey, Moderna

☆ Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
▼ + stars: | 2024-06-28 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +19 min

But other current employees are dissatisfied with where the strategy shift has left them. In January 2023, Pfizer forecast a steep drop in annual revenue, to between $67 billion and $71 billion. Pfizer's 2023 revenue ultimately came in at $58.5 billion, including $11.22 billion from its Covid vaccine and $1.28 billion from Paxlovid. Faith in executive leadership also plunged among some workers, according to most of the current and former employees who spoke with CNBC. Some current workers said that hasn't appeared to change after the town hall on May 2.

Persons: Albert Bourla, Wall, they're, Bourla, I'm, drugmaker Seagen, Irfan Khan, hasn't, Pfizer, renegotiating, John Thys, Payal Sahni Becher, Becher, Kena, Mike McDermott, Bourla's Organizations: Corbis, Getty, Pfizer, Wall, CNBC, Los Angeles Times, Moderna, Centers for Disease Control, U.S ., GSK, Bristol Myers Squibb, Pfizer wasn't, . Biotech, Companies, Biotech, BioNtech, Reuters, Human, View Press, Global, APEC, Summit, Tech, Google Locations: U.S, Covid, Eagle Rock , California, Durham , North Carolina, Puurs, Belgium, New York City, Peapack , New Jersey, Kena

☆ AI helped crack COVID, and now 83% of Moderna employees use ChatGPT daily, says chief brand officer Kate Cronin
▼ + stars: | 2024-06-24 | by ( Julia Hood | ) www.businessinsider.com time to read: 1 min

Link icon An image of a chain link. It symobilizes a website link url. Link icon An image of a chain link. Copy LinkTwitter LinkedIn icon LinkedIn Link icon An image of a chain link. Twitter LinkedIn icon LinkedIn Link icon An image of a chain link.

☆ 3 actions extraordinary people take to achieve what seems impossible, from the co-founder of Moderna
▼ + stars: | 2024-06-11 | by ( Alex Koller | ) www.cnbc.com time to read: +3 min

If you need to tackle an improbable challenge, the right mindset — "a special kind of optimism" — can help, according to Moderna co-founder and chairman Noubar Afeyan. Specifically, Afeyan — who has an estimated net worth of $1.5 billion, according to Forbes — said that "extraordinary change agents" take three actions to achieve what seems impossible:They imagine. Imagination plays a crucial role "in accomplishing impossible missions," Afeyan said: You typically need to think creatively to come up with new, original ideas. But ask yourself one central question: Why do we expect extraordinary results from reasonable people doing reasonable things?" "You need to leave your comfort zone, to think in new ways, to acclimate to the unfamiliar and embrace uncertainty."

Persons: Noubar Afeyan, he's, Afeyan —, Forbes —, Afeyan, Allison Butler, Butler Organizations: Moderna, Massachusetts Institute of Technology, MIT, Sloan School of Management, Bryant University, CNBC Locations: Lebanon, Canada, Massachusetts, Cambodia, California, Cambridge, acclimate

☆ CNBC Daily Open: Apple upgrades Siri with AI
▼ + stars: | 2024-06-11 | by ( Abid Ali | ) www.cnbc.com time to read: +3 min

This report is from today's CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. Apple IntelligenceShares of Apple fell 1.9% after the iPhone maker delivered its long-awaited AI strategy. Siri will get an upgrade with Apple Intelligence and access to OpenAI's ChatGPT. Investors are concerned Apple had fallen behind its rivals, Microsoft and Google, in the race to deliver AI services and tools.

Persons: Goldman Sachs, Siri, Apple, Elon Musk's, Chris Ailman, CNBC's, Ailman, CalSTRS, Elliott, Moderna, Tesla, Elon, Bernstein Organizations: CNBC, Nasdaq, Technology, Nvidia, Meta, Microsoft, Dow Jones, Apple Intelligence, Apple, Investors, Google, California State Teachers, Elliott, Southwest, Elliott Management, Southwest Airlines, Boeing, Pfizer, Novavax Locations: U.S

☆ 5 things to know before the stock market opens
▼ + stars: | 2024-06-11 | by ( Sean Conlon | ) www.cnbc.com time to read: +4 min

At Apple's annual Worldwide Developers Conference on Monday, the company unveiled "Apple Intelligence" – its long-awaited AI software. Apple CEO Tim Cook stressed privacy and personalization with the system, moving beyond AI into "personal intelligence." Siri will also be getting some upgrades with Apple Intelligence, and Apple announced that Siri will also be able to tap into ChatGPT when needed through the company's partnership with OpenAI. The activist hedge fund has taken a $1.9 billion stake in Southwest Airlines , which makes it one of the airline's biggest investors. This follows a number of other stakes the firm has built within the past two months, such as a $2.5 billion stake in Texas Instruments, a $2 billion stake in SoftBank and a $1 billion stake in Anglo American.

Persons: Tim Cook, John Giannandrea, Craig Federighi, Nic Coury, Siri, Elliott, Gary Hershorn, it's, Bob Jordan, Gary Kelly, Fred Tanneau, Stephane Bancel, Francis Scott Key, Michael A Organizations: Nasdaq, Dow Jones, Nvidia, Apple, Developers, AFP, Getty, Apple Intelligence, OpenAI, Max, Southwest Airlines, Hollywood International Airport, Corbis, Elliott Management, Texas, Moderna, Afp, Francis Scott Key Bridge, McCoy, Washington Post Locations: Cupertino , California, Fort Lauderdale, Fort Lauderdale , Florida, SoftBank, U.S, Baltimore

☆ Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
▼ + stars: | 2024-06-10 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

Moderna on Monday said its combination vaccine that targets both Covid-19 and the flu was more effective than existing standalone shots for those viruses in a late-stage trial. Moderna's messenger RNA combination shot, called mRNA-1083, is made up of both the company's vaccine candidate for seasonal influenza and a newer, "next-generation" version of its Covid shot. The study compared the combination shot with an enhanced flu vaccine called Fluzone HD and Moderna's currently licensed Covid shot, Spikevax, in one group of patients ages 65 and above. Moderna is also developing a combination shot targeting the flu and RSV, and another vaccine targeting all three respiratory viruses: Covid, flu and RSV. Meanwhile, Pfizer and BioNTech also are studying a vaccine that targets both Covid and the flu in a late-stage trial.

Persons: Stephane Bancel, Novavax, Bancel, Moderna, BioNTech Organizations: Pfizer, Novavax, Moderna, Covid Locations: U.S

☆ Moderna’s combination flu & Covid vaccine is more effective than existing shots in late-stage trial
▼ + stars: | 2024-06-10 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailModerna’s combination flu & Covid vaccine is more effective than existing shots in late-stage trialModerna CEO Stephane Bancel joins 'Squawk Box' to discuss the data from its phase three trial of a combination flu and Covid-19 vaccine, the company's vaccine pipeline outlook, and more.

Persons: Stephane Bancel

☆ Covid-flu combination vaccine shows positive results in late-stage trial, Moderna says
▼ + stars: | 2024-06-10 | by ( Jen Christensen | ) edition.cnn.com time to read: +5 min

CNN —There could be a combined Covid-19 and flu shot in our future, although it won’t be ready for this year’s flu season. On Monday, vaccine maker Moderna announced positive late-stage trial results for its Covid/flu combination vaccine it calls mRNA-1083. Other companies have been testing a combined Covid-flu vaccine, but Moderna is the first to announce positive late-stage trial results. The trial studied the vaccine in two different age groups with about 4,000 adults in each age category. Few people got the latest Covid shot, studies show.

Persons: ”, Francesca Ceddia, ” Ceddia, Covid, Spikevax, Moderna, Sue Peschin, Dr, Sanjay Gupta, Peschin, ” Peschin, “ Organizations: CNN, Moderna, Public, US Centers for Disease Control, Food, Covid, FDA, Alliance for Aging Research, CNN Health, CDC Locations: United States

☆ FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
▼ + stars: | 2024-06-07 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +4 min

But the virus can also cause severe illness in adults 50 and up — or even younger — with underlying chronic conditions such as asthma, diabetes and congestive heart failure. GSK's shot won't reach that new patient population just yet. Safety data in adults ages 50 to 59 was also consistent with data in adults 60 and above, according to GSK. Regulatory agencies in Europe, Japan and other areas are currently reviewing GSK's application to expand Arexvy's approval to high-risk adults ages 50 to 59. GSK's shot is approved in nearly 50 countries, a spokesperson for the company told CNBC.

Persons: Phil Dormitzer, Dormitzer, Luke Miels, Arexvy, GSK's Organizations: Drug Administration, GSK, FDA, Centers for Disease Control, CNBC, CDC, Pfizer, Moderna, U.S Locations: British, Europe, Japan

Search resuls for: "Moderna"

25 mentions found